Coreceptor restriction within the HLA-DQ locus for Epstein–Barr virus infection

AUTOR(ES)

Haan, Keith M.

FONTE

The National Academy of Sciences

RESUMO

Epstein–Barr virus (EBV) is a ubiquitous human herpesvirus that causes infectious mononucleosis and is etiologically associated with malignancies of multiple origins. EBV enters cells through a cascade of interactions between its envelope glycoprotein gp350 and the gp42-gH-gL complex with cellular receptors. Membrane fusion is catalyzed by the binding of gp42, a member of the C type lectin family, to HLA class II molecule HLA-DR, -DP, or -DQ. Here we demonstrate that only a subset of HLA-DQ alleles mediates EBV entry, indicating that individuals expressing these alleles may offer unique sites for EBV infection and subsequent sequelae. Additionally, the specific site within HLA-DQ determined to be essential for EBV entry is homologous to a site within MHC class I shown by structural studies to bind to the C type-lectin-like natural killer receptor, providing insight into the biochemical nature of the gp42–HLA class II interaction.

Documentos Relacionados

• Epstein-Barr Virus Entry Utilizing HLA-DP or HLA-DQ as a Coreceptor
• Endogenous retroviral long terminal repeats within the HLA-DQ locus.
• Ancient roots for polymorphism at the HLA-DQ alpha locus in primates.
• Transcriptional enhancers in the HLA-DQ subregion.
• HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virus.